Israeli biopharmaceutical company Eloxx Pharmaceuticals Inc. appointed Jasbir Seehra to its board.
Seehra is president and CEO of Keros Therapeutics Inc., a privately owned Lexington, Mass.-based biotech firm.
Eloxx Pharmaceuticals appoints director
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Israeli biopharmaceutical company Eloxx Pharmaceuticals Inc. appointed Jasbir Seehra to its board.
Seehra is president and CEO of Keros Therapeutics Inc., a privately owned Lexington, Mass.-based biotech firm.